Cannabix Partner Omega Labs to Showcase Marijuana Breath Test at NDASA Conference
Event summary
- Omega Laboratories will host two educational panels at the 2026 NDASA Conference in Orange County, California, April 26–29.
- Panels will highlight Cannabix's Marijuana Breath Test (MBT) and its impact on employee screening programs.
- MBT detects delta-9 THC in breath within 4 hours of consumption, addressing limitations of traditional cannabis testing methods.
- Omega has completed method development and validation work on the MBT and continues to integrate the technology into its laboratory services.
The big picture
As recreational and medical cannabis use expands globally, employers face increasing pressure to adopt testing methods that are fair and relevant. Breath-based detection of delta-9 THC provides a scientifically validated method to evaluate recent use, supporting workplace safety and compliance. Omega's participation at NDASA 2026 underscores the growing need for practical solutions that measure recent cannabis use, helping employers navigate the complexities of cannabis legalization.
What we're watching
- Adoption Pace
- How quickly employers and safety-sensitive industries will integrate breath-based cannabis testing into existing frameworks.
- Regulatory Alignment
- Whether the MBT can sustain its relevance as cannabis laws and workplace policies continue to evolve.
- Competitive Positioning
- The pace at which Cannabix and Omega can differentiate their solution from traditional cannabis testing methods.
Related topics